ANTCF (Aion Therapeutic) Change In Inventory: $-0.02 Mil (TTM As of Jan. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Aion Therapeutic Change In Inventory?

Aion Therapeutic ANTCF Change In Inventory is $-0.02 Mil as of Jan. 2025.

Aion Therapeutic's change in inventory for the quarter that ended in Jan. 2025 was $0.13 Mil. It means Aion Therapeutic's inventory declined by $0.13 Mil from Oct. 2024 to Jan. 2025 .

Aion Therapeutic's change in inventory for the fiscal year that ended in Apr. 2024 was $-0.06 Mil. It means Aion Therapeutic's inventory increased by $0.06 Mil from Apr. 2023 to Apr. 2024 .

Aion Therapeutic's Total Inventories for the quarter that ended in Jan. 2025 was $0.28 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Aion Therapeutic's Days Inventory for the quarter that ended in Jan. 2025 was 85.47.

Inventory Turnover measures how fast the company turns over its inventory within a year. Aion Therapeutic's Inventory Turnover for the quarter that ended in Jan. 2025 was 1.07.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Aion Therapeutic's Inventory-to-Revenue for the quarter that ended in Jan. 2025 was 0.91.

Aion Therapeutic  (OTCPK:ANTCF) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Aion Therapeutic's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=0.34980816675242/0.37345590835471*365 / 4
=85.47

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Aion Therapeutic's Inventory Turnover for the quarter that ended in Jan. 2025 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=0.37345590835471 / 0.34980816675242
=1.07

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Aion Therapeutic's Inventory to Revenue for the quarter that ended in Jan. 2025 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=0.34980816675242 / 0.38364133827197
=0.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aion Therapeutic Change In Inventory Related Terms

Aion Therapeutic Change In Inventory Historical Data

* Premium members only.

The historical data trend for Aion Therapeutic's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aion Therapeutic Change In Inventory Chart

Aion Therapeutic Annual Data
Trend Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Change In Inventory
Get a 7-Day Free Trial - - - - -0.06

Aion Therapeutic Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.02 -0.09 -0.04 0.13

Aion Therapeutic Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of $-0.02 Mil mean?
Aion Therapeutic (ANTCF) has a Change In Inventory of $-0.02 Mil as of Jan. 2025. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Aion Therapeutic and its competitors.
Is Aion Therapeutic's Change In Inventory too high?
Aion Therapeutic's current Change In Inventory is $-0.02 Mil.
How does Aion Therapeutic's Change In Inventory compare to CBDY and GRPS?
Aion Therapeutic's Change In Inventory of $-0.02 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Drug Manufacturers company?
A good Change In Inventory depends on the Drug Manufacturers industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Aion Therapeutic and its competitors. Aion Therapeutic's current Change In Inventory is $-0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aion Therapeutic stock overvalued right now?
Aion Therapeutic (ANTCF) has a current Change In Inventory of $-0.02 Mil. The current Change In Inventory is $-0.02 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Aion Therapeutic (ANTCF), the current Change In Inventory is $-0.02 Mil as of Jan. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aion Therapeutic Business Description

Address 700 West Georgia Street, Suite 2200, Vancouver, BC, CAN, V7Y 1K8
Aion Therapeutic Inc is in the business of research and development, treatment, data mining, and state of the art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals, and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery. During the year ended the Company had one operating segment, being health and wellness, dedicated to delivering state-of-the-art water filtration solutions. Geographically company earns revenue from USA.